DOUGLAS MATSUNAGA
Ophthalmology Physician · LOS ANGELES, CA
Individual Active NPI 1821450818
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 519 | 7,266 | $2,643,990 | $986,314 | $767,735 |
| 2023 | 494 | 4,829 | $2,169,122 | $757,330 | $592,146 |
| 2022 | 105 | 409 | $233,790 | $69,409 | $54,708 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 2,820 | $34 | $27 |
| 92134 | Imaging of retina | 1,165 | $43 | $33 |
| 92014 | Established patient complete exam of visual system | 930 | $136 | $99 |
| 67028 | Injection of drug into eye | 476 | $132 | $100 |
| J0178 | Injection, aflibercept, 1 mg | 422 | $829 | $656 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 244 | $232 | $182 |
| J9035 | Injection, bevacizumab, 10 mg | 188 | $72 | $56 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 85 | $179 | $129 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 30 | $27 | $18 |
| 92012 | Established patient problem focused exam of visual system | 25 | $96 | $70 |
| 76512 | 2d ultrasound scan of eye tissue and structures | 22 | $52 | $32 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 16 | $16 | $9 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | A168505 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1962412643
- NPI 1679758544
- NPI 1992992945
- NPI 1073816070
- NPI 1942369699
- NPI 1295000693
- NPI 1073730081
- NPI 1801390216
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.